25 May 2013
Keywords: Sanofi-Aventis, R&D president
Article | 15 December 2010
In a second high-profile management change in less than a week, French drug major Sanofi-Aventis (Euronext: SAN) yesterday announced the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.